id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0002-0948,FDA,FDA-1977-N-0002,Withdrawal of Certain Proposed Rules and Other Proposed Actions,Proposed Rule,Withdrawal,2004-12-08T05:00:00Z,2004,12,2004-11-25T05:00:00Z,,2019-07-11T01:05:36Z,04-26234,0,0,09000064805d7039
FDA-1976-N-0027-0017,FDA,FDA-1976-N-0027,Notice of Proposed Rulemaking re OTC Nasal Decongestant Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-11-02T05:00:00Z,2004,11,2004-11-01T05:00:00Z,2005-02-01T04:59:59Z,2015-10-29T20:31:58Z,,0,0,090000648051b771
FDA-2003-P-0346-0002,FDA,FDA-2003-P-0346,"Proposed Rule re Microbiology Devices; Reclassification of Hepatitis A Virus (HAV) Serological Assays (IgM Antibody, IgG Antibody and Total Antibodies [IgM and IgG])",Proposed Rule,NPR-Notice of Proposed Rule-Making,2004-09-30T04:00:00Z,2004,9,2004-09-29T04:00:00Z,2004-12-30T04:59:59Z,2024-11-25T16:34:43Z,69FR58371,0,0,0900006480496e02
FDA-1998-P-0014-0001,FDA,FDA-1998-P-0014,Prevention of Salmonella Enteritidis in Shell Eggs During Production,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-09-27T04:00:00Z,2004,9,2004-09-27T04:00:00Z,2004-12-22T04:59:59Z,2021-08-20T01:00:35Z,04-21219,0,0,0900006480559764
FDA-2004-N-0450-0001,FDA,FDA-2004-N-0450,"Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph for Over-the-Counter Nasal Decongestant Drug Products; Proposed Rule",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-08-03T04:00:00Z,2004,8,2004-08-02T04:00:00Z,2004-11-02T04:59:59Z,2025-04-24T18:56:04Z,04-17445,0,0,09000064804753f5
FDA-2004-N-0189-0001,FDA,FDA-2004-N-0189,"Notice of Proposed Rule from FDA/CFSAN re Recordkeeping Requirements for Human Food and Cosmetics Manufactured from Processed With, or Otherwise Containing Material form Cattle",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-07-15T04:00:00Z,2004,7,2004-07-14T04:00:00Z,2004-08-14T03:59:59Z,2015-06-02T15:08:45Z,,0,0,09000064804708ea
FDA-2004-N-0191-0002,FDA,FDA-2004-N-0191,Definition of Primary Mode of Action of a Combination Product,Proposed Rule,Extension of Comment Period,2004-06-25T04:00:00Z,2004,6,2004-06-24T04:00:00Z,2004-08-21T03:59:59Z,2025-04-22T11:40:20Z,04-14265,0,0,0900006480470985
FDA-2004-N-0061-0001,FDA,FDA-2004-N-0061,Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-06-14T04:00:00Z,2004,6,2004-06-09T04:00:00Z,2004-09-09T03:59:59Z,2016-02-05T22:00:35Z,,0,0,090000648046ebfe
FDA-1998-N-0088-0003,FDA,FDA-1998-N-0088,Exports; Notification and Recordkeeping Requirements; Advance Notice of Proposed Rulemaking,Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2004-06-04T04:00:00Z,2004,6,2004-06-01T04:00:00Z,2004-08-17T03:59:59Z,2015-12-15T22:00:39Z,,0,0,0900006480585e6e
FDA-2004-N-0191-0001,FDA,FDA-2004-N-0191,Definition of Primary Mode of Action of a Combination Product,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-05-12T00:00:00Z,2004,5,2004-05-07T00:00:00Z,2004-07-07T03:59:59Z,2025-05-09T04:34:42Z,04 10447,0,0,0900006480470980
FDA-2004-N-0240-0001,FDA,FDA-2004-N-0240,Notice of Proposed Rulemaking re Requirements Pertaining to Sampling Services and Private Laboratories used in Connection with Imported Food,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-05-07T04:00:00Z,2004,5,2004-04-26T04:00:00Z,2004-07-29T03:59:59Z,2016-02-01T15:38:30Z,,0,0,09000064804718ed
FDA-2003-N-0313-0001,FDA,FDA-2003-N-0313,Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-04-23T04:00:00Z,2004,4,2004-04-21T04:00:00Z,2004-07-22T03:59:59Z,2016-02-09T22:01:05Z,,0,0,0900006480494e6b
FDA-1998-N-0043-0002,FDA,FDA-1998-N-0043,Gastroenterology-Urology Devices; Classification for External Penile Rigidity Devices,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2004-03-19T05:00:00Z,2004,3,2004-03-17T05:00:00Z,2004-06-16T03:59:59Z,2024-09-17T12:30:40Z,04–5983,0,0,090000648056e633
FDA-2003-N-0213-0001,FDA,FDA-2003-N-0213,Orthopedic Devices; Effective Date of the Proposed Requirement for Premarket Approval of the Hip Joint Metal/Polymer or Ceramic/Polymer Semiconstrained Resurfacing Cemented Prosthesis,Proposed Rule,NPR-Notice of Proposed Rule-Making,2004-03-10T05:00:00Z,2004,3,2004-03-05T05:00:00Z,2004-06-04T03:59:59Z,2008-11-17T08:26:07Z,,0,0,090000648048c2bd